Nutrient signaling to mTOR and cell growth

Jenna L Jewell1, Kun-Liang Guan

  • 1Department of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093, USA.

Insights

The mammalian target of rapamycin (mTOR) pathway regulates cell growth and is often hyperactivated in cancers. This review details nutrient-driven mTORC1 activation, a critical but poorly understood process.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Oncology

Background:

  • The mammalian target of rapamycin (mTOR) is a key protein kinase regulating cellular processes like growth.
  • Aberrant mTOR activation is implicated in human cancers, with mTOR inhibitors showing clinical efficacy.
  • mTOR exists in two complexes, mTORC1 and mTORC2, with differential regulation by growth factors and nutrients.

Purpose of the Study:

  • To review the current understanding of nutrient-dependent regulation of mTORC1.
  • To elucidate the molecular mechanisms underlying amino acid-induced mTORC1 activation.

Main Methods:

  • Literature review of existing studies on mTORC1 regulation.
  • Analysis of molecular pathways involved in nutrient sensing and mTORC1 activation.

Main Results:

  • mTORC1, but not mTORC2, is sensitive to nutrient availability, including glucose and amino acids.
  • Despite its importance, the precise mechanisms of amino acid-induced mTORC1 activation remain incompletely understood.

Conclusions:

  • Understanding nutrient regulation of mTORC1 is crucial given its role in cell growth and cancer.
  • Further research is needed to fully unravel the complexities of amino acid signaling to mTORC1.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...